Savannah Margaret Aitcheson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Savannah Margaret Aitcheson has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Rachael Zoe Murray
Queensland University of Technology, Australia
3 shared publications - Annalese Barbara Trudy Semmler
School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia
2 shared publications - Sheree E. Hurn
Queensland University of Technology, Australia
2 shared publications - Eva Hatje
Centre for Immunology and Infection Control, Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia
1 shared publication - Francesca D. Frentiu
School of Biomedical Sciences, Centre for Immunology and Infection Control, Queensland University of Technology, Brisbane, QLD 4000, Australia
1 shared publication - Henk Huijser
Queensland University of Technology
1 shared publication
Latest Publications
- Open Access
- 8 September 2025
- Published by Open Access Publishing Association in Journal of University Teaching and Learning Practice
- Vol. 22 (4)
Increasing student survey participation through single-subject interventions affecting concurrent subjects
Student evaluations of teaching (SET) surveys are a widely debated tool used by universities worldwide for quality assurance and improvement. Low response rates often result in non-response bias, significantly undermining their validity. While numerous evidence-based strategies exist to improve response rates, the importance of achieving higher rates to enhance the usefulness of these surveys is frequently underestimated, and applying these strategies across all subjects can be time-consuming and costly. Previous research has not specifically explored whether interventions in one subject could encourage greater student participation in SETs for other concurrently studied subjects. In this study at an Australian metropolitan university, we demonstrate that by targeting key health subjects with a combination of three evidence-based strategies, response rates almost doubled in both targeted and untargeted subjects the same students were studying. This also enhanced response quality, as measured by the length and lexical diversity of open-ended responses. The improved response rates for all subjects were observed regardless of learning modes (blended or online-only), enrolment type (undergraduate or postgraduate), or whether students were on placement. These findings suggest that targeted interventions could encourage students to complete all their SET surveys. The benefits are clear: increased survey participation across multiple subjects can reduce non-respondent bias while minimising the burden of survey promotion. Our study contributes to the body of knowledge guiding university decision-makers in increasing student feedback to improve teaching quality.
- 8 September 2025
- Published by Open Access Publishing Association in Journal of University Teaching and Learning Practice
- Vol. 22 (4)
Open AccessIncreasing student survey participation through single-subject interventions affecting concurrent subjects
Student evaluations of teaching (SET) surveys are a widely debated tool used by universities worldwide for quality assurance and improvement. Low response rates often result in non-response bias, significantly undermining their validity. While numerous evidence-based strategies exist to improve response rates, the importance of achieving higher rates to enhance the usefulness of these surveys is frequently underestimated, and applying these strategies across all subjects can be time-consuming and costly. Previous research has not specifically explored whether interventions in one subject could encourage greater student participation in SETs for other concurrently studied subjects. In this study at an Australian metropolitan university, we demonstrate that by targeting key health subjects with a combination of three evidence-based strategies, response rates almost doubled in both targeted and untargeted subjects the same students were studying. This also enhanced response quality, as measured by the length and lexical diversity of open-ended responses. The improved response rates for all subjects were observed regardless of learning modes (blended or online-only), enrolment type (undergraduate or postgraduate), or whether students were on placement. These findings suggest that targeted interventions could encourage students to complete all their SET surveys. The benefits are clear: increased survey participation across multiple subjects can reduce non-respondent bias while minimising the burden of survey promotion. Our study contributes to the body of knowledge guiding university decision-makers in increasing student feedback to improve teaching quality.
The trans‐SNARE complex VAMP4/Stx6/Stx7/Vti1b is a key regulator of Golgi to late endosome MT1‐MMP transport in macrophages
The activity of the matrix metalloproteinase (MMP) MT1‐MMP is strictly regulated by expression and cellular location. In macrophages LPS activation leads to the up‐regulation of MT1‐MMP and this need to be at the cell surface for them to degrade the dense extracellular matrix (ECM) components to create a path to migrate into injured and infected tissues. Fixed and live imaging shows newly made MT1‐MMP is packaged into vesicles that traffic to and fuse with LBPA+LAMP1+ late endosomes en route to the surface. The R‐SNARE VAMP4, found on Golgi‐derived vesicles that traffic to late endosomes, forms a trans‐SNARE complex with the Q‐SNARE complex Stx6/Stx7/Vti1b. The Stx6/Stx7/Vti1b complex has been shown to be up‐regulated in lipopolysaccharide (LPS)‐activated cells to increase trafficking of key cytokines through the classical pathway and now we show here it is up‐regulation also plays a role in the late endosomal pathway of MT1‐MMP trafficking. Depletion of any of the SNAREs in this complex reduces surface MT1‐MMP and gelatin degradation. Conversely, overexpression of the Stx6/Stx7/Vti1b components increases surface MT1‐MMP levels. This suggests that Stx6/Stx7/Vti1b is a key Q‐SNARE complex in macrophages during an immune response and in partnership with VAMP4 it regulates transport of newly made MT1‐MMP.
The trans‐SNARE complex VAMP4/Stx6/Stx7/Vti1b is a key regulator of Golgi to late endosome MT1‐MMP transport in macrophages
The activity of the matrix metalloproteinase (MMP) MT1‐MMP is strictly regulated by expression and cellular location. In macrophages LPS activation leads to the up‐regulation of MT1‐MMP and this need to be at the cell surface for them to degrade the dense extracellular matrix (ECM) components to create a path to migrate into injured and infected tissues. Fixed and live imaging shows newly made MT1‐MMP is packaged into vesicles that traffic to and fuse with LBPA+LAMP1+ late endosomes en route to the surface. The R‐SNARE VAMP4, found on Golgi‐derived vesicles that traffic to late endosomes, forms a trans‐SNARE complex with the Q‐SNARE complex Stx6/Stx7/Vti1b. The Stx6/Stx7/Vti1b complex has been shown to be up‐regulated in lipopolysaccharide (LPS)‐activated cells to increase trafficking of key cytokines through the classical pathway and now we show here it is up‐regulation also plays a role in the late endosomal pathway of MT1‐MMP trafficking. Depletion of any of the SNAREs in this complex reduces surface MT1‐MMP and gelatin degradation. Conversely, overexpression of the Stx6/Stx7/Vti1b components increases surface MT1‐MMP levels. This suggests that Stx6/Stx7/Vti1b is a key Q‐SNARE complex in macrophages during an immune response and in partnership with VAMP4 it regulates transport of newly made MT1‐MMP.
- Top Cited PapersOpen Access
Skin Wound Healing: Normal Macrophage Function and Macrophage Dysfunction in Diabetic Wounds
Macrophages play a prominent role in wound healing. In the early stages, they promote inflammation and remove pathogens, wound debris, and cells that have apoptosed. Later in the repair process, they dampen inflammation and secrete factors that regulate the proliferation, differentiation, and migration of keratinocytes, fibroblasts, and endothelial cells, leading to neovascularisation and wound closure. The macrophages that coordinate this repair process are complex: they originate from different sources and have distinct phenotypes with diverse functions that act at various times in the repair process. Macrophages in individuals with diabetes are altered, displaying hyperresponsiveness to inflammatory stimulants and increased secretion of pro-inflammatory cytokines. They also have a reduced ability to phagocytose pathogens and efferocytose cells that have undergone apoptosis. This leads to a reduced capacity to remove pathogens and, as efferocytosis is a trigger for their phenotypic switch, it reduces the number of M2 reparative macrophages in the wound. This can lead to diabetic foot ulcers (DFUs) forming and contributes to their increased risk of not healing and becoming infected, and potentially, amputation. Understanding macrophage dysregulation in DFUs and how these cells might be altered, along with the associated inflammation, will ultimately allow for better therapies that might complement current treatment and increase DFU’s healing rates.
Top Cited PapersOpen AccessSkin Wound Healing: Normal Macrophage Function and Macrophage Dysfunction in Diabetic Wounds
Macrophages play a prominent role in wound healing. In the early stages, they promote inflammation and remove pathogens, wound debris, and cells that have apoptosed. Later in the repair process, they dampen inflammation and secrete factors that regulate the proliferation, differentiation, and migration of keratinocytes, fibroblasts, and endothelial cells, leading to neovascularisation and wound closure. The macrophages that coordinate this repair process are complex: they originate from different sources and have distinct phenotypes with diverse functions that act at various times in the repair process. Macrophages in individuals with diabetes are altered, displaying hyperresponsiveness to inflammatory stimulants and increased secretion of pro-inflammatory cytokines. They also have a reduced ability to phagocytose pathogens and efferocytose cells that have undergone apoptosis. This leads to a reduced capacity to remove pathogens and, as efferocytosis is a trigger for their phenotypic switch, it reduces the number of M2 reparative macrophages in the wound. This can lead to diabetic foot ulcers (DFUs) forming and contributes to their increased risk of not healing and becoming infected, and potentially, amputation. Understanding macrophage dysregulation in DFUs and how these cells might be altered, along with the associated inflammation, will ultimately allow for better therapies that might complement current treatment and increase DFU’s healing rates.